KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $23.3 million.

  • Charles River Laboratories International's Share-based Compensation rose 2036.11% to $23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.7 million, marking a year-over-year decrease of 206.58%. This contributed to the annual value of $69.9 million for FY2024, which is 299.38% down from last year.
  • Per Charles River Laboratories International's latest filing, its Share-based Compensation stood at $23.3 million for Q3 2025, which was up 2036.11% from $17.0 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Share-based Compensation high stood at $23.3 million for Q3 2025, and its period low was $13.1 million during Q1 2025.
  • Moreover, its 5-year median value for Share-based Compensation was $17.1 million (2021), whereas its average is $17.9 million.
  • Per our database at Business Quant, Charles River Laboratories International's Share-based Compensation soared by 3054.53% in 2021 and then plummeted by 2152.59% in 2025.
  • Over the past 5 years, Charles River Laboratories International's Share-based Compensation (Quarter) stood at $19.2 million in 2021, then grew by 15.03% to $22.1 million in 2022, then fell by 11.55% to $19.5 million in 2023, then decreased by 11.71% to $17.2 million in 2024, then soared by 35.0% to $23.3 million in 2025.
  • Its Share-based Compensation stands at $23.3 million for Q3 2025, versus $17.0 million for Q2 2025 and $13.1 million for Q1 2025.